These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35 related articles for article (PubMed ID: 8880947)
1. Fenfluramine: riddle or Rosetta stone? Weir EK; Obreztchikova M; Hong Z Eur Respir J; 2008 Feb; 31(2):232-5. PubMed ID: 18238944 [No Abstract] [Full Text] [Related]
2. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity. Anchors M Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245 [No Abstract] [Full Text] [Related]
3. Fen-phen manufacturers, not physicians, are liable. Allen S; Henderson J Tex Med; 2000 May; 96(5):62-4. PubMed ID: 10843016 [No Abstract] [Full Text] [Related]
5. [Valvular heart disease and primary pulmonary hypertension associated with fenfluramine-phentermine]. Wolf I; Mouallem M; Farfel Z Harefuah; 1998 Dec; 135(11):515-7. PubMed ID: 10911468 [No Abstract] [Full Text] [Related]
6. Selections from current literature: pharmacological treatment of obesity. Connolly J; Verni C; Trilling J; Kelso E; Shiesha S Fam Pract; 1998 Feb; 15(1):88-93. PubMed ID: 9527304 [No Abstract] [Full Text] [Related]
7. Brain serotonin neurotoxicity and primary pulmonary hypertension from fenfluramine and dexfenfluramine. A systematic review of the evidence. McCann UD; Seiden LS; Rubin LJ; Ricaurte GA JAMA; 1997 Aug; 278(8):666-72. PubMed ID: 9272900 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary hypertension as a result of drug therapy. Higenbottam T; Laude L; Emery C; Essener M Clin Chest Med; 2004 Mar; 25(1):123-31. PubMed ID: 15062604 [TBL] [Abstract][Full Text] [Related]